Claims
- 1. A method for inactivating biomacromolecules by administering an effective amount of an ANSA derivative of the formula:
- 2. The method according to claim 1 wherein the biomacromolecules are bacteria.
- 3. The method accordant to claim 1 wherein the biomacromolecules are fungi.
- 4. The method according to claim 1 wherein the biomacromolecules are viruses.
- 5. The method according to claim 1, wherein the biomacromolecules are enzymes.
- 6. The method according to claim 6, wherein the enzymes are bacterial enzymes.
- 7. The method according to claim 1, wherein the biomacromolecules are regulatory transcription factors or receptors.
- 8. The method according to claim 1 wherein the biomacromolecules are cancer cells.
- 9. A method for inactivating biomacromolecules by administering an effective amount of an ANSA derivative of the formula:
- 10. Derivatives of ANSA of the following formula:
- 11. Pharmaceutical compositions for inactivating proteins comprising an effective amount of a compound according to claim 10 and a pharmaceutically acceptable carrier.
- 12. Derivatives of ANSA of the following formulae:
- 13. Pharmaceutical compositions for inactivating proteins comprising an effective amount of a compound according to claim 12 and pharmaceutically acceptable carrier.
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] The present application is a continuation of Ser. No. 09/988,397, filed Nov. 19, 2001, which claims priority from provisional application Serial No. 60/249,277, filed Nov. 17, 2000, the entire contents of which are hereby incorporated by reference.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60249277 |
Nov 2000 |
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
09988397 |
Nov 2001 |
US |
Child |
10186301 |
Jul 2002 |
US |